Ingredient

Sotatercept

Sotatercept is a protein-based medication used in the treatment of pulmonary arterial hypertension.

See medicines used for Chronic Conditions
All medicines
4
Single ingredient
4
Prescription medication
4

MFDS ingredient code M285534

What does it do?

Sotatercept is a biological agent of the protein class, used to improve vascular function in patients with pulmonary arterial hypertension. This ingredient regulates signaling pathways involved in the control of cellular growth within blood vessels.

Sotatercept helps to inhibit excessive proliferation of cells in the blood vessels and dilates the vessels to lower blood pressure. This reduces pressure in the pulmonary artery and alleviates the burden on the heart.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike conventional vasodilators, sotatercept has a unique mechanism of action that regulates growth factor signaling. This provides a new approach for the treatment of pulmonary arterial hypertension and can be used in combination with other therapies.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

4 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.